ROTUNNO, GIADA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.606
EU - Europa 1.830
AS - Asia 462
AF - Africa 12
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.917
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.598
PL - Polonia 471
RU - Federazione Russa 364
IT - Italia 341
IE - Irlanda 214
SE - Svezia 170
CN - Cina 164
SG - Singapore 115
HK - Hong Kong 84
CH - Svizzera 70
DE - Germania 54
FI - Finlandia 42
JO - Giordania 38
GB - Regno Unito 35
IN - India 33
FR - Francia 25
ES - Italia 17
VN - Vietnam 14
CI - Costa d'Avorio 11
BE - Belgio 8
CA - Canada 8
AT - Austria 5
UA - Ucraina 5
BG - Bulgaria 4
TW - Taiwan 4
BR - Brasile 3
KR - Corea 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
JP - Giappone 2
NL - Olanda 2
RO - Romania 2
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
GR - Grecia 1
MY - Malesia 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 4.917
Salva come PNG Salva come JPEG
Città #
Warsaw 466
Fairfield 414
Ashburn 247
Woodbridge 225
Chandler 222
Dublin 214
Seattle 200
Cambridge 158
Houston 154
Wilmington 147
Ann Arbor 112
Florence 85
Altamura 82
Lawrence 80
Singapore 75
Bern 70
Beijing 63
Princeton 60
Buffalo 46
Hong Kong 46
Boston 33
Bremen 30
Shanghai 29
San Diego 26
Mumbai 25
New York 24
Moscow 23
Medford 21
Los Angeles 18
Barcelona 15
Helsinki 15
Kent 15
Boardman 14
Dearborn 12
Dong Ket 12
Abidjan 11
Hillsboro 11
Rome 11
Santa Clara 11
Norwalk 9
Brussels 8
Claymont 8
Pune 7
Cagliari 6
Fiesole 6
Fuzhou 6
Hangzhou 6
Hefei 6
Pian di Scò 6
London 5
Vienna 5
Andover 4
Blagoevgrad 4
Cantagallo 4
Jacksonville 4
Milan 4
Nanjing 4
Paris 4
Red Deer 4
Redwood City 4
Romainville 4
Berlin 3
Brescia 3
Faenza 3
Jinan 3
Kilburn 3
Munich 3
Nanchang 3
Pavia 3
Phoenix 3
Rochester 3
San Jose 3
Seoul 3
São Paulo 3
Abu Dhabi 2
Bologna 2
Burghausen 2
Cedar Knolls 2
Cipolletti 2
Costa Mesa 2
Falls Church 2
Guangzhou 2
Islington 2
Kunming 2
Maranello 2
Nürnberg 2
Padova 2
Pisa 2
Poggio A Caiano 2
Reston 2
Rhinelander 2
Rimini 2
San Gavino Monreale 2
Sesto Fiorentino 2
Seville 2
Siena 2
Taibao 2
Toronto 2
Villa Minozzo 2
Washington 2
Totale 3.731
Salva come PNG Salva come JPEG
Nome #
Study of mutation complexity in Chronic Myeloproliferative Neoplasms: pathogenetic insights and translational relevance 270
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis 243
Feasibility of a workflow for the molecular characterization of single cells by next generation sequencing 185
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer 173
MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis 160
Epidemiology and clinical relevance of mutations in post-polycythemia vera and post-essential thrombocythemia myelofibrosis. A study on 359 patients of the AGIMM group 146
Targeted deep sequencing in polycythemia vera and essential thrombocythemia 130
Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients 126
Spectrum of ASXL1 mutations in primary myelofibrosis: Prognostic impact of the ASXL1 p.G646Wfs∗12 mutation 125
Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms 121
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients 120
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis 119
Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib 116
JAK2V617F complete molecular remission in polycythemia vera/essential thrombocythemia patients treated with ruxolitinib 115
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis 113
Mutations and prognosis in primary myelofibrosis. 112
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 111
Co-targeting the PI3K/mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms. 108
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 106
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in Primary Myelofibrosis 104
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea 101
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. 100
Involvement of RUNX1 Pathway Is a Common Event in the Leukemic Transformation of Chronic Myeloproliferative Neoplasms (MPNs) 99
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria. 96
Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms. 94
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis 94
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value. 93
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis. 91
Mutational analysis of BCORL1 in the leukemic transformation of chronic myeloproliferative neoplasms. 88
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia. 85
Validation of the Mayo alliance prognostic system for mastocytosis 84
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project 83
Calreticulin: a new horizon for the testing and treatment of myeloproliferative neoplasms. 81
What Do Molecular Tests Add to Prognostic Stratification in MF: Is It Time to Add These to Our Clinical Practice? 78
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients. 76
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC project 72
Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia 72
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features 63
Prognotic Impact of Mutations in Systemic Mastocytosis 60
Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera 58
A case of aleukemic mast cell leukemia with an underlying myeloproliferative neoplasm: Morphological and molecular characteristics of a highly aggressive disease 56
BRAFV600E mutation in the wrong place: a case of concomitant polycythemia vera, hairy cell leukemia, and thyroid adenoma 51
null 47
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis 47
Characteristics and clinical correlates of NFE2 mutations in chronic Myeloproliferative neoplasms 46
Lenalidomide: A double-edged sword for concomitant multiple myeloma and post-essential thrombocythemia myelofibrosis 45
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera 40
Molecular Characterization of Response/Loss-of-Response to Ruxolitinib in Patients with Myelofibrosis 37
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis 32
Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement 31
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis 29
Prognostic relevance of mutations in myelofi-brosis 28
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients 24
CALR mutation burden in essential thrombocythemia and disease outcome 19
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms 14
The prognostic contribution of CBL, NRAS, KRAS, RUNX1, and TP53 mutations to mutation-enhanced international prognostic score systems (MIPSS70/plus/plus v2.0) for primary myelofibrosis 13
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates 12
Totale 5.042
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.502
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.502
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.020 0 0 17 105 134 135 150 149 123 84 99 24
2020/2021619 42 64 13 120 29 49 31 40 67 76 54 34
2021/2022379 9 8 48 17 20 21 13 40 20 14 74 95
2022/20231.160 87 228 72 79 71 173 140 89 103 13 26 79
2023/2024481 25 40 64 18 51 60 12 102 11 32 34 32
2024/2025561 84 283 194 0 0 0 0 0 0 0 0 0
Totale 5.042